Chargement en cours...
Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial
OBJECTIVE: To examine whether treatment with epigallocatechin gallate (EGCG) influences progression of brain atrophy, reduces clinical and further radiologic disease activity markers, and is safe in patients with progressive multiple sclerosis (PMS). METHODS: We enrolled 61 patients with primary or...
Enregistré dans:
| Publié dans: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7954462/ https://ncbi.nlm.nih.gov/pubmed/33622766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000964 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|